Health experts in Kenya have raised an alarm over the severe shortage of Bacillus Calmette-Guérin (BCG), the life-saving childhood vaccine that has been out of stock in government stores and hospitals ...

Health experts have raised an alarm over the severe shortage of Bacillus Calmette-Guérin (BCG), the life-saving childhood ...

A new study published in the Journal of Internal Medicine showed that it may be possible to prevent the formation of ...

Academic researchers in Massachusetts believe the standard BCG (bacillus Calmette-Guérin) vaccine could have a remarkable second use: a treatment to reverse advanced type 1 diabetes. The cause of ...

The bacillus Calmette–Guérin (BCG) vaccine, initially developed to provide protection against TB, also protects against leprosy; and the magnitude of this effect varies. Previous meta-analyses ...

(NASDAQ: IBRX), today announced the opening of a clinical trial to study ANKTIVA® (nogapendekin alfa inbakicept-pmln) together with the investigational AdHER2DC vaccine (autologous dendritic ...

As of November 2024, 100 patients with Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer with carcinoma in situ (NMIBC CIS) have been treated with ANKTIVA ...

Indeed, the BCG vaccine was invented whether the leprosy world asked for it or not; and it has not been necessary to consider the need for neonatal BCG vaccination to prevent leprosy, or to ...

We use cookies to improve your browsing experience and provide essential website functionality. You may accept or manage your choices by clicking below. These choices will not affect browsing data. If ...